VCEL
VericelCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Operating peers and competitors
Source-backed product markets and frozen research comparisons. Valuation comparators remain in the existing peer table.
Loading market evidence...
Research comparisons do not establish forecast usefulness or trading returns.
Compare shared product markets
Membership only; no portfolio weights or estimated losses.
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
VCEL vs peer average
52/100
VCEL vs. peer average (C vs. C)
Grade spread
A 3 · B 1 · D 2 · F 3
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
ANIP is the first available peer comparator.
ANI Pharmaceuticals is a closer small-cap specialty-pharma size comp than a business-line comp; it is useful mainly for small-cap biotech valuation context, not for cartilage repair or burn-care operating read-throughs.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
VCEL
Vericel
ANIP
ANI
Grade
C
A
Momentum
80
59
Value
59
68
Sentiment
43
56
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ANIP
VCEL / ANIP
Grade Position
In line
VCEL vs. peer average (C vs. C)
52/100
Momentum
80
VCELValue
59
ANIPSentiment
43
ANIPRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs VCEL
ANIP is the first peer returned for this comparison set.